DCN, as an inhibitor of TGF-β1 and an activator of the VEGF pathway, may promote the occurrence and development of OLP by suppressing the expression of TGF-β1 and increasing VEGF expression to facilitate angiogenesis. This evidence concerns the gene DCN and oral lichen planus.